Scientists in Germany, Peru and Taiwan to Lose Access to Elsevier Journals
Libraries pursue alternative delivery routes after licence negotiations break down.
Send us a link
Libraries pursue alternative delivery routes after licence negotiations break down.
The EU’s fresh round of billion-euro Flagship research projects must be open to all types of science.
Political compromise settles immigration row that could have severed Swiss–EU research agreements.
Recommendation engine Instrumentl aims to speed grant searching.
Poor experimental design and statistical analysis could contribute to widespread problems in reproducing preclinical animal experiments.
The University of California, Berkeley, and the Broad Institute are vying for lucrative rights to the gene-editing system.
Sociologist Matthijs Rooduijn explains why the darkening political mood must force academics to step up and choose sides.
The trend of turning universities into businesses is limiting research freedoms in traditionally liberal institutes in northern Europe.
If funding applications were made under open access, science would benefit from more universal scrutiny.
All the videos and slides from #scidata16.
Scientists should challenge online falsehoods and inaccuracies — and harness the collective power of the Internet to fight back, argues Phil Williamson.
Technology and practice can help shy and introverted researchers to succeed when reticence is risky.
Books have the power to trigger a lifelong urge to know more about the world and its environs.
Economic woes wrought by globalization are only part of the cause.
Consortium backed by US NIH is first major biology programme to mandate online publication of results ahead of peer review.
In an era of online discussion, debate must remain nuanced and courteous.
If politicians can lie without condemnation, what are scientists to do? Kathleen Higgins offers some explanation.
Guest post by Professor Elizabeth Loftus, winner of the 2016 John Maddox Prize
But grave challenges remain before the promise of individually tailored medicine becomes reality.
20% of the scientists undertook between 69% and 94% of reviews last year.
Following a £2 billion research pledge, questions remain around commitment to boost science investment.